...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New PP on SEDAR

Or something new or developing rapidly, that makes the timeframe believable and enticing? One can attempt to read the tea leaves, with optimism and hope? RVX is rocketing today, with huge volume and a solid increase in pps percentage.  May not mean anything, but better than the usual poke in the eye with a sharp stick.

Share
New Message
Please login to post a reply